PPT-Overcoming Multidrug Resistance in Breast Cancer: Targeting MRP Proteins for Enhanced
Author : ezekiel | Published Date : 2024-09-06
Camryn Tims Rajib Biswas Treiveanna Jenkins Anup Kundu PhD Biology Department Xavier University Tulane University Health Sciences Center In this project the MDR
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "Overcoming Multidrug Resistance in Breas..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Overcoming Multidrug Resistance in Breast Cancer: Targeting MRP Proteins for Enhanced: Transcript
Camryn Tims Rajib Biswas Treiveanna Jenkins Anup Kundu PhD Biology Department Xavier University Tulane University Health Sciences Center In this project the MDR proteins will be targeted as the major resistant protein in the cancer cell lines When MRP1P. nbcamorg reast cancer is the second most common kind of cancer in women About 1 in 8 women born today in the United States will get breast cancer at some point The good news is that many women can survive breast cancer if its found and treated earl nbcamorg reast cancer is the second most common kind of cancer in women About 1 in 8 women born today in the United States will get breast cancer at some point The good news is that many women can survive breast cancer if its found and treated earl ENERGY CONTRAST ENHANCED SPECTRAL . MAMMOGRAM : . AS A PROBLEM SOLVING TOOL IN EQUIVOCAL . CASES. Abstract . ID . IRIA-1121. B. reast . cancer incidence has increased by more than . 20% ,mortality . Homework problems: . 2,6,7,8,9,13.. 1. MRP Foundation. Material requirements planning (MRP):. A computer-based information system that translates master schedule requirements for end items into time-phased requirements for subassemblies, components, and raw materials.. LT . Christina Jamros, DO (Associate. ) . CDR . Ryan Maves, MD (Fellow. ) . CAPT . Mary . Bavaro. , MD (Fellow). Department of Internal . Medicine. Naval . Medical Center, San Diego, CA. Disclosure. I have no relevant financial relationships with any commercial supporters.. Inspection. Size. S. ymmetry (some variation is normal) . Shape. Contour (flattening, masses, and dimpling). S. kin (color, edema, rashes, thickening, and venous pattern). S. cars (previous surgery, injuries). Julie R. Gralow, M.D.. Director, Breast Medical Oncology. Jill Bennett Endowed Professor of Breast Cancer. Professor, Global Health. University of Washington School of Medicine. Fred Hutchinson Cancer Research Center. Carbapenems. . Customize this presentation with your organization’s logo, etc.. 1. 3/17/2014. Presentation Objectives. Brief overview on microbiology and antibiotics. Describe antibiotic resistant organisms with a focus on . group. of diseases. . All forms of cancer cause cells in the body to change and grow out of control. . Most types of cancer cells form a lump or mass called a . tumor. . . The tumor can invade and destroy healthy tissue. Cells from the tumor can break away and travel to other parts of the body. There they can continue to grow. . 1.BackgroundofresearchThereisanemergenceofmultidrugresistantbacteriawhichareunabletotreatwithmultipleantibacterialdrugs.Multidrugresistantbacterialinfectionsarebecominganimportantproblemfacinghealthca Dierberg KL, Dorjee K, Salvo F, Cronin WA, Boddy J, Cirillo D, et al. Improved Detection of Tuberculosis and Multidrug-Resistant Tuberculosis among Tibetan Refugees, India. Emerg Infect Dis. 2016;22(3):463-468. https://doi.org/10.3201/eid2203.140732. March 2019. Preview/Introduction. The Risk of Breast Cancer to Women. Does Mammography Save Lives?. When to Start and How Often Should Women Screen?. Risks Versus Benefits of Mammography. Breast Cancer: The Impact on Women. Azeez Farooki, MD. Attending Physician, Clinical Member. Memorial Sloan Kettering Cancer Center. New York, NY. Objectives. Elucidate the problem of aromatase inhibitor induced bone loss and increased risk of fractures in breast cancer. John Stelling, MD, MPH, . jstelling@whonet.org. Brigham and Women’s Hospital, Harvard Medical School, Boston. WHO Collaborating Centre for Surveillance of Antimicrobial Resistance. Webinar agenda. Comments on the WHONET Webinar series.
Download Document
Here is the link to download the presentation.
"Overcoming Multidrug Resistance in Breast Cancer: Targeting MRP Proteins for Enhanced"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents